Published in J Cancer on January 15, 2014
The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Front Immunol (2014) 0.86
Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies. Mediators Inflamm (2016) 0.83
Macrophage-tumor cell fusions from peripheral blood of melanoma patients. PLoS One (2015) 0.82
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A (2009) 4.19
Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity (2005) 4.06
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A (2009) 3.87
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer (2008) 3.04
CD44 cell adhesion molecules. Mol Pathol (1999) 2.89
Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc Natl Acad Sci U S A (2009) 2.84
Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol (2007) 2.78
Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature (1993) 2.68
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol (2003) 2.50
Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med (Berl) (2005) 2.48
Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov (2011) 2.45
Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44
Expression of CD68 in non-myeloid cell types. Scand J Immunol (2008) 2.32
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol Immunol (2003) 2.24
CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem (2000) 2.15
Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity (2013) 2.08
Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies. Clin Cancer Res (2013) 2.07
Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol (1990) 1.94
Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate (1999) 1.92
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood (1997) 1.89
Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol (2005) 1.86
CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. Blood (2013) 1.74
Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment. Cancer Microenviron (2009) 1.60
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood (2005) 1.57
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer. Proc Natl Acad Sci U S A (2013) 1.54
Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta (2010) 1.50
Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood (2004) 1.50
Activated leukocyte cell adhesion molecule: a new paradox in cancer. Transl Res (2007) 1.49
The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res (1997) 1.43
Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol (2005) 1.41
Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway. Cancer Res (2005) 1.41
Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery. Proc Natl Acad Sci U S A (2012) 1.40
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci U S A (2002) 1.40
Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion. Cancer Res (2007) 1.39
CD146, a multi-functional molecule beyond adhesion. Cancer Lett (2012) 1.36
Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis (1996) 1.35
Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol (2010) 1.32
Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells. J Bone Miner Metab (2006) 1.29
Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone (2010) 1.27
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases. J Cell Physiol (2011) 1.27
Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res (1994) 1.24
Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science (2012) 1.24
Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay. Calcif Tissue Int (2005) 1.23
The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res (2013) 1.22
NOTCHing the bone: insights into multi-functionality. Bone (2009) 1.19
Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res (1993) 1.17
Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues. Eur J Endocrinol (2010) 1.16
Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model. Int J Cancer (2008) 1.13
Epithelial-mesenchymal transition, TGF-β, and osteopontin in wound healing and tissue remodeling after injury. J Burn Care Res (2012) 1.12
Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer--response. Clin Cancer Res (2013) 1.11
CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases. Ann Surg Oncol (2009) 1.07
Expression of macrophage antigens by tumor cells. Adv Exp Med Biol (2011) 1.07
Small cell carcinoma of the lung: macrophage-specific antigens suggest hemopoietic stem cell origin. Science (1984) 1.06
Human mesenchymal stromal cells express CD14 cross-reactive epitopes. Cytometry A (2011) 1.06
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential. PLoS One (2012) 1.04
Integrated cross-species transcriptional network analysis of metastatic susceptibility. Proc Natl Acad Sci U S A (2012) 1.03
Cytokine-regulated expression of activated leukocyte cell adhesion molecule (CD166) on monocyte-lineage cells and in rheumatoid arthritis synovium. Arthritis Rheum (1998) 1.03
Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo. Proc Natl Acad Sci U S A (2012) 1.02
Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin. Br J Dermatol (1997) 1.02
Insights into the cell of origin in breast cancer and breast cancer stem cells. Asia Pac J Clin Oncol (2010) 1.02
Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape. Cancer Lett (2011) 1.01
Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. J Biol Chem (2007) 0.99
ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression. Mol Cancer Res (2011) 0.99
Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer. Oral Oncol (2013) 0.98
Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma. Cancer Lett (2011) 0.97
A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion. Oncogene (2011) 0.96
Dentin matrix protein 1 is expressed in human lung cancer. J Bone Miner Res (2003) 0.94
Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. Int J Clin Exp Pathol (2013) 0.94
Cell fusion promotes chemoresistance in metastatic colon carcinoma. Oncogene (2012) 0.93
CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood (1998) 0.93
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer. Clin Cancer Res (2012) 0.92
MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells. J Leukoc Biol (2002) 0.92
Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitro evidence. BMC Biol (2013) 0.92
Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice. Breast Cancer Res Treat (2009) 0.91
The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines. PLoS One (2011) 0.90
Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo. Cancer Invest (2012) 0.90
CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in Epithelial to Mesenchymal Transition. PLoS One (2012) 0.90
LPS promotes pre-osteoclast activity by up-regulating CXCR4 via TLR-4. J Dent Res (2011) 0.90
Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines. Cancer Immunol Immunother (2009) 0.90
Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene. Cancer Res (2004) 0.89
Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J Biol Chem (1993) 0.89
Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type. Mol Cancer (2013) 0.89
Estradiol down-regulates CD36 expression in human breast cancer cells. Cancer Lett (2004) 0.88
Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers. Mol Cancer (2013) 0.88
Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers. Int J Cancer (1997) 0.88
The functional interaction between CD98 and CD147 in regulation of virus-induced cell fusion and osteoclast formation. Med Microbiol Immunol (2003) 0.88
CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasis. APMIS (2007) 0.88
Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact. Histol Histopathol (2009) 0.88
Stimulation of CD40 inhibits Fas- or chemotherapy-mediated apoptosis and increases cell motility in human gastric carcinoma cells. Int J Oncol (2003) 0.88
NF-κB plays a key role in inducing CD274 expression in human monocytes after lipopolysaccharide treatment. PLoS One (2013) 0.87
Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion? Contrib Microbiol (2006) 0.87
Haematopoietic lineage-committed bone marrow cells, but not cloned cultured mesenchymal stem cells, contribute to regeneration of renal tubular epithelium after HgCl 2 -induced acute tubular injury. Cell Prolif (2008) 0.87
An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice. J Immunol (2005) 0.87
Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma. Oral Oncol (2010) 0.87
From sentinel to messenger: an extended phenotypic analysis of the monocyte to dendritic cell transition. Immunology (1998) 0.87
Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: reciprocal roles of Tspan-5 and NET-6 during osteoclastogenesis. Allergol Int (2007) 0.86
Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor. Cell Growth Differ (1996) 0.86
LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro. BMC Cancer (2012) 0.86
Perspectives on the mesenchymal origin of metastatic cancer. Cancer Metastasis Rev (2010) 0.86
Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Regul Pept (2010) 0.85